Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,785 | -34,661 | -21,218 | -16,362 | -12,085 |
| Depreciation Amortization | 24 | 114 | 69 | 65 | 51 |
| Income taxes - deferred | 231 | 226 | N/A | N/A | N/A |
| Other Working Capital | 2,116 | -211 | -325 | -680 | -455 |
| Other Operating Activity | 10,436 | 15,015 | 10,099 | 9,686 | 9,393 |
| Operating Cash Flow | $-4,978 | $-19,516 | $-11,374 | $-7,291 | $-3,097 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -7 | N/A | N/A | N/A |
| Net Acquisitions | N/A | 2 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $-4 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 8,855 | 8,855 | 8,855 | 8,855 |
| Other Financing Activity | 0 | 22,668 | -456 | 0 | 0 |
| Financing Cash Flow | $N/A | $31,523 | $8,399 | $8,855 | $8,855 |
| Beginning Cash Position | 17,814 | 5,811 | 5,811 | 5,811 | 5,811 |
| End Cash Position | 12,836 | 17,814 | 2,836 | 7,375 | 11,569 |
| Net Cash Flow | $-4,978 | $12,003 | $-2,975 | $1,564 | $5,758 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,978 | -19,516 | -11,374 | -7,291 | -3,097 |
| Capital Expenditure | N/A | -7 | N/A | N/A | N/A |
| Free Cash Flow | -4,978 | -19,523 | -11,374 | -7,291 | -3,097 |